The medtech industry is shifting from insights-driven AI to autonomous, action-oriented systems. While GenAI has accelerated adoption, it remains constrained in regulated environments due to limitations in reliability, explainability and compliance.
Agentic AI is emerging as the next step—purpose-built, goal-oriented systems designed to operate within clinical and regulatory boundaries while delivering real-time outcomes.
This Everest Group whitepaper, supported by HCLTech, explores the transition and presents a practical, implementation-focused perspective on scaling Agentic AI in medtech.